Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

被引：0
|
作者：
Chang, Julie E. [1 ]
Kenkre, Vaishalee P. [2 ]
Fletcher, Christopher D. [3 ]
Hall, Aric C. [4 ]
Callander, Natalie Scott [5 ]
Kim, Kyungmann [6 ]
Chen, Grace Yi [6 ]
Chambers, Kaitlin [7 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Wisconsin, Madison, WI USA
[3] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
[4] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Hematol Oncol, Madison, WI USA
[5] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[6] Univ Wisconsin, Dept Biostat, Madison, WI USA
[7] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124489
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5470
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy
    Kim, Myung Sun
    Prasad, Vinay
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 560 - 561
  • [2] Consolidation Treatment with Lenalidomide Following Front-line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
    Strati, Paolo
    Keating, Michael
    Burger, Jan
    O'Brien, Susan
    Wierda, William
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S299 - S300
  • [3] Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia
    Strati, Paolo
    Keating, Michael J.
    Burger, Jan A.
    O'Brien, Susan M.
    Wierda, William G.
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    [J]. HAEMATOLOGICA, 2017, 102 (12) : 494 - 496
  • [4] Consolidation Treatment with Lenalidomide Following Front-line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
    Strati, Paolo
    Keating, Michael J.
    Burger, Jan A.
    O'Brien, Susan M.
    Wierda, William G.
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S12 - S13
  • [5] Front-Line Therapy for Chronic Lymphocytic Leukemia
    Desai, Sheetal
    Pinilla-Ibarz, Javier
    [J]. CANCER CONTROL, 2012, 19 (01) : 26 - 36
  • [6] Rituximab as first-line and maintenance therapy for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL).
    Hainsworth, JD
    Litchy, S
    Burris, HA
    Greco, FA
    [J]. BLOOD, 2001, 98 (11) : 363A - 363A
  • [7] Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma
    Chang, Julie E.
    Wang, Tuo
    Kim, KyungMann
    Folstad, Matthew
    Endres, Mariah
    Howard, Mitch
    Kenkre, Vaishalee
    Fletcher, Christopher
    Rajguru, Saurabh
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [8] Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia
    Reagan, John L.
    Castillo, Jorge J.
    [J]. FUTURE ONCOLOGY, 2014, 10 (07) : 1147 - 1155
  • [9] Bendamustine plus rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: AWisconsin Oncology Network Study
    Chang, Julie E.
    Havighurst, Thomas
    Kim, KyungMann
    Eickhoff, Jens
    Traynor, Anne M.
    Kirby-Slimp, Rachel
    Volk, Lynn M.
    Werndli, Jae
    Go, Ronald S.
    Weiss, Matthias
    Blank, Jules
    Kahl, Brad S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (02) : 283 - 291
  • [10] What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Benjamin N. Voorhies
    Deborah M. Stephens
    [J]. Current Treatment Options in Oncology, 2017, 18
12345